Ignite Creation Date:
2024-05-05 @ 4:59 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00360269
Status:
COMPLETED
Last Update Posted:
2014-12-30
First Post:
2006-08-02
Brief Title:
Atomoxetine Treatment for ADHD and Marijuana Dependence
Sponsor:
Medical University of South Carolina
Organization:
Medical University of South Carolina
Study Overview
Official Title:
Atomoxetine Treatment for ADHD and Marijuana Dependence
Status:
COMPLETED
Status Verified Date:
2014-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to determine if atomoxetine treatment combined with motivational enhancement therapy is effective in reducing marijuana use in adult individuals with attention-deficit hyperactivity disorder and marijuana dependence
Detailed Description:
The purpose of this study is to determine whether the medication atomoxetine or Strattera plus 3 sessions of counseling can help people to reduce the symptoms of ADHD and to help cut back on their marijuana use Participation in the study is approximately 12 weeks of medication treatment and doctors visits once a week The first 2 visits consist of evaluations to determine if you qualify to participate These visits are approximately 2-3 hours long and will include questions about your past and present substance use psychiatric history a routine physical exam bloodwork and paper and pencil questionnaires about your marijuana use Once you are enrolled in the study visits are typically 30 minutes long once a week The one-on-one counseling sessions regarding marijuana use are 1 hour long and you will have 3 sessions throughout the study If you qualify for this study you will receive either atomoxetine or a placebo sugar pill Study participants will have a 50 chance of receiving atomoxetine Atomoxetine is a non-stimulant commonly used to treat ADHD
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R21DA018221 | NIH | None | httpsreporternihgovquickSearchR21DA018221 |